
Quotient Limited QTNT
Quarterly report 2023-Q3
added 05-23-2026
Quotient Limited Depreciation & Amortization 2011-2026 | QTNT
Annual Depreciation & Amortization Quotient Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.2 M | 8.8 M | 12.5 M | 12.7 M | 10.3 M | 9.38 M | 2.86 M | 1.18 M | 519 K | 337 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.7 M | 337 K | 6.57 M |
Quarterly Depreciation & Amortization Quotient Limited
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 2.34 M | 2.15 M | 1.94 M | 2.34 M | 9 M | 6.07 M | 3.04 M | 2.9 M | 9.5 M | 6.42 M | 3.33 M | 3.06 M | 9.5 M | 6.42 M | - | 2.58 M | 7.68 M | 5.08 M | 2.46 M | 2.37 M | 1.57 M | 907 K | 398 K | 643 K | 938 K | 599 K | 282 K | 316 K | 938 K | 282 K | - | - | 376 K | 240 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9.5 M | 240 K | 3.09 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
321 M | $ 115.58 | 0.45 % | $ 35.1 B | ||
|
Celcuity
CELC
|
167 K | $ 132.39 | -1.4 % | $ 6.19 B | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 7.51 | -17.56 % | $ 9.99 M | ||
|
Castle Biosciences
CSTL
|
40.8 M | $ 21.34 | 8.38 % | $ 619 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
1.4 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
24.1 M | $ 17.56 | -0.65 % | $ 540 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 21.63 | 0.42 % | $ 1.15 B | ||
|
Guardant Health
GH
|
39.7 M | $ 122.77 | 2.43 % | $ 15.4 B | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.8 | - | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 117.97 | 3.62 % | $ 9.73 B | ||
|
Illumina
ILMN
|
354 M | $ 144.89 | -0.23 % | $ 23 B | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 99.54 | -0.52 % | $ 6.72 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 163.83 | 4.65 % | $ 8.12 B | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 099.36 | -0.18 % | $ 22.7 B | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
36.1 M | $ 9.46 | 2.05 % | $ 1.21 B | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 433.51 | 1.02 % | $ 12.5 B | ||
|
National Research Corporation
NRC
|
7.62 M | $ 19.15 | 0.58 % | $ 429 M | ||
|
Natera
NTRA
|
16.7 M | $ 199.66 | -0.62 % | $ 19.6 B | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 3.87 | 0.52 % | $ 358 M | ||
|
Personalis
PSNL
|
10 M | $ 8.97 | 0.34 % | $ 800 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 26.61 | -1.28 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 6.29 | -2.18 % | $ 262 M | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.02 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.38 | -3.73 % | $ 5.47 M | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 64.28 | -0.91 % | $ 3.84 B | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 259.15 | 0.28 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
1.05 B | $ 450.44 | 0.49 % | $ 170 B | ||
|
Waters Corporation
WAT
|
88.1 M | $ 343.56 | 1.44 % | $ 20.5 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.26 | 1.26 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 194.51 | 0.83 % | $ 21.6 B |